Combination antiretroviral therapy is associated with reduction in liver fibrosis scores in patients with HIV and HBV co-infection

BACKGROUND: Liver fibrosis is common in individuals with HIV/HBV co-infection, but whether cART could reverses liver fibrosis is unclear. METHODS: This was a retrospective observational study. Binary logistic regression was used to assess predictors of liver fibrosis in individuals with HIV/HBV co-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Rongrong, Gui, Xien, Ke, Hengning, Xiong, Yong, Gao, Shicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684625/
https://www.ncbi.nlm.nih.gov/pubmed/34924016
http://dx.doi.org/10.1186/s12981-021-00419-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684625/
https://www.ncbi.nlm.nih.gov/pubmed/34924016
http://dx.doi.org/10.1186/s12981-021-00419-y

Ejemplares similares